About US
Contact us
-
U.K. looks to slash branded drug prices up to 20%Government looking at cuts to drugs that fall outside PPRS Makersof branded drugs have been fighting a rising tide of price pressure in the U.K. and Europe, where protectors of government health plan2013/6/24
-
EU grants U.S. API makers exemption from certification ruleThe FDA has gotten the coveted waiver from the European Commission from its new rules for imported APIs less than two weeks before the rule is set to go into effect on July 2. It means that APIs manuf2013/6/24
-
Official stresses joint efforts to ensure food safetyChinese Vice Premier Wang Yang has called for combined efforts including enterprises' self-discipline, government supervision and public scrutiny to promote food safety in the country. Wang made the2013/6/20
-
AMA's obesity ruling could inspire new drug effortsThe AMA's decision to classifyobesityas a disease is a direct attempt to persuade biopharma companies to develop new therapies by making it harder for payers to decline coverage while applying pressur2013/6/20
-
ILE Stand Design Drawing on CPhI China 2013ILE Pharmaceutical Materials Co. sincerely invites you to visit CPhI, ICSE & BiDate: June 25th– 27th, 2013 Address: Shanghai New International Expo Center ( No. 2345 Longyang Road, Pudong District2013/6/19
-
AstraZeneca homes in on new HQ and research site in CambridgeAstraZeneca's new CEO has zeroed in on a site for its new headquarters and R&D center in the U.K. Over the next three years the pharma company ($AZN) plans to build a $500 million complex on an 112013/6/19
-
Newly minted Sanofi diabetes med fails to impress German pricing regulatorsSanofi's ($SNY) newdiabetesdrug has hit a setback in Germany. The country's increasingly strict pricing regulators say Lyxumia delivers "no additional benefit" compared with existing drugs. If the dec2013/6/18
-
FDA probes long-acting Zyprexa safety after 2 patients dieTwo patients have died unexpectedly after their Zyprexa Relprevv injections, and the FDA is now investigating. The agency says the patients died three to four days after receiving "an appropriate dose2013/6/18
-
Elan goes on the block in the final hour of takeover fightElanis officially up for sale. Seeking to dodge a hostile takeover bid fromRoyalty Pharma, the Irish company said Friday morning that it has begun a formal sales process,Reutersreports, and invited Ro2013/6/17
-
Wockhardt gets kicked in the gut againThere is more financially painful news for India'sWockhardt. India has banned the sale of painkiller dextropropoxyphene, and Wockhardt's branded version, Proxyvon, made up about 4% of its sales. That2013/6/17